"10.1371_journal.pone.0082879","plos one","2013-12-30T00:00:00Z","Michael Zech; Georg Nübling; Florian Castrop; Angela Jochim; Eva C Schulte; Brit Mollenhauer; Peter Lichtner; Annette Peters; Christian Gieger; Thorsten Marquardt; Marie T Vanier; Philippe Latour; Hans Klünemann; Claudia Trenkwalder; Janine Diehl-Schmid; Robert Perneczky; Thomas Meitinger; Konrad Oexle; Bernhard Haslinger; Stefan Lorenzl; Juliane Winkelmann","Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany; Institute of Epidemiology II, Helmholtz Zentrum München, Munich, Germany; Institute of Genetic Epidemiology, Helmholtz Zentrum München, Munich, Germany; Institut für Humangenetik, Technische Universität München, Munich, Germany; Neurologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany; Paracelsus-Elena-Klinik, Kassel, Germany; Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, United Kingdom; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London, United Kingdom; Klinik für Psychiatrie und Psychotherapie, Universität Regensburg, Regensburg, Germany; Neurochirurgische Klinik, Georg-August-Universität, Göttingen, Germany; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany; Laboratoire Gillet-Mérieux, CBPE, Hospices Civils de Lyon, Lyon, France; UF de Neurogénétique Moléculaire, CBPE, Hospices Civils de Lyon, Lyon, France; Munich Cluster for Systems Neurology, SyNergy, Munich, Germany; Department of Neurology and Neurological Sciences and Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America","Conceived and designed the experiments: MZ GN ECS BH SL JW. Performed the experiments: MZ GN ECS. Analyzed the data: MZ GN ECS BH SL JW. Contributed reagents/materials/analysis tools: MZ GN FC AJ ECS BM P. Lichtner AP CG T. Marquardt MV P. Latour HK CT JDS RP KO T. Meitinger BH SL JW. Wrote the paper: MZ GN JW.","MZ has received travel expenses form Actelion Pharmaceuticals Ltd. FC has received funding for travel from Medtronic. AJ has received funding for travel from Allergan and Ipsen Pharmaceuticals. BM received travel compensation from Novartis and Boehringer-Ingelheim, lecturing fees from Orion and Glaxo-Smith-Kline, grant support from GE Healthcare, Boehringer-Ingelheim, Desitin, TEVA-Pharma, and serves as a consultant to Bayer-Schering Pharma and the Michael J. Fox Foundation for Parkinsons Disease Research. MV has received travel expenses, carried out paid and unpaid consultancy work, and presentation honoraria from Actelion Pharmaceuticals Ltd., and has received travel expenses, presentation honoraria, and been invited to meetings funded and organized by Genzyme Corporation and Shire HGT. PLa has received presentation honoraria from Actelion Pharmaceuticals France. HK has received travel expenses, carried out paid consultancy work, and received presentation honoraria from Actelion Pharmaceuticals Ltd. CT serves on scientific advisory boards for Boehringer Ingelheim and UCB, has received speaker honoraria from Boehringer Ingelheim, UCB, and Mundipharma as well as travel compensation from UCB, Boehringer-Ingelheim, and Mundipharma. TMei was supported by the German Network for Mitochondrial Disorders (mitoNET 01GM0867), the European Commission Seventh Framework Program (N. 261123), Genetic European Variation in Disease Consortium, and German Ministry for Education and Research (01GR0804-4). BH serves on a scientific advisory board for Merz Pharmaceuticals; has received funding for travel from Biogen Idec, Ipsen, and Merz Pharmaceuticals; has received speaker honoraria from Allergan and Ipsen, and receives research support from Ipsen and the DFG. SL received grants from UCB Pharma, TEVA, Boehringer, Grünenthal, Orion. JW serves on a scientific advisory board for UCB; has received speaker honoraria from UCB and Boehringer Ingelheim; has filed a patent re: Winkelmann et al. Nat Genet 2007; and receives research support from the German RLS foundation, the Deutsche Forschungsgemeinschaft (DFG) and the Fritz Thyssen Foundation. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Michael Zech","MZ",21,TRUE,6,3,6,3,TRUE,TRUE,TRUE,8,"9;10;11;13;14;15;17;18",TRUE
